• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Meta-Analysis Links Structured Exercise to Functional Improvements in Neuromuscular Diseases

by
November 16, 2026
in Health
Reading Time: 6 mins read
0
Meta-Analysis Links Structured Exercise to Functional Improvements in Neuromuscular Diseases

Meta-Analysis Links Structured Exercise to Functional Improvements in Neuromuscular Diseases

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A comprehensive systematic review and meta-analysis published in Frontiers in Public Health indicates that structured exercise training is associated with improved average functional outcomes in individuals with myopathies and related neuromuscular diseases. The primary random-effects meta-analysis of 13 randomized controlled trials encompassing 403 participants demonstrated a statistically significant positive effect favoring exercise (Hedges’ g = 0.567, 95% confidence interval 0.268 to 0.867; t(12) = 4.12; p = 0.001). However, the authoring team, led by Xinglong Chen, rated overall evidence certainty as low under the GRADE framework. A critical caveat is that the calculated 95% prediction interval ranged from −0.243 to 1.377. Because this interval crosses zero, the true functional effect in a comparable future trial could range from substantial improvement to no benefit or slight deterioration.

The underlying pathology across the examined conditions presents substantial biological diversity. Myopathies primarily affect skeletal muscle tissue, including metabolic myopathies, inflammatory conditions such as polymyositis and dermatomyositis, and progressive muscular dystrophies. In contrast, related neuromuscular diseases encompass disorders of motor neurons, peripheral nerves, and neuromuscular transmission. Despite shared clinical manifestations—such as weakness, fatigue, and diminished exercise capacity restricting mobility and daily activities—disease mechanisms, trajectories, and exercise-associated risks differ substantially across diagnoses. Consequently, the authors emphasized that an average positive functional effect across pooled trials cannot be interpreted as equivalent clinical benefit or identical safety for every distinct diagnosis or clinical phenotype.

To evaluate comparative evidence, the investigators searched five electronic databases through October 5, 2026: Web of Science, Cochrane Library, SPORTDiscus, Embase, and PubMed. Database searches identified 3,149 records: 906 from Web of Science, 1,591 from Cochrane Library, 17 from SPORTDiscus, 420 from Embase, and 215 from PubMed. Following duplicate removal (683 records), 2,466 unique records were screened, excluding 2,397 records at title and abstract screening. All 69 reports sought for retrieval were obtained and evaluated. Full-text assessment excluded 47 reports due to population (17), intervention (5), outcomes (18), and study design (7). Ultimately, 22 reports representing 21 independent studies and 614 participants were included in the review, yielding a corrected quantitative dataset of 21 valid functional effects from 13 independent randomized trials.

The review adhered to PRISMA 2020 guidelines under a retrospective PROSPERO protocol registration (CRD420251230000) registered on April 26, 2026, following the recorded November 30, 2025 start date. For the quantitative dose analysis, researchers calculated planned weekly active exercise volume in minutes per week as session duration multiplied by weekly frequency. Warm-up and cool-down periods were excluded, and comparator exercise volume was deducted from intervention exposure. This metric captured planned rather than completed exercise duration, without weighting for intensity, modality, or adherence. Although the registered protocol permitted linear and quadratic models, the limited number of dose-ready trials led authors to restrict evaluation to an exploratory linear meta-regression, reporting no quadratic curves or turning points.

The 13 randomized trials contributing to the primary meta-analysis reflected diverse conditions, interventions, and functional outcome measures. Cejudo et al. (2005) evaluated exercise in 18 mitochondrial myopathy patients, recording improved endurance distance (Hedges’ g = 1.301). In facioscapulohumeral muscular dystrophy, Bankolé et al. (2016) noted minimal six-minute walk test change in 16 participants (g = 0.008), whereas Voet et al. (2014) observed marked fatigue reductions on the Checklist Individual Strength scale among 52 patients (g = 1.481). In myotonic dystrophy type 1, Kierkegaard et al. (2011) evaluated 34 patients on the six-minute walk test (g = 0.258), and Wenninger et al. (2025) combined respiratory arms against a common control in 25 participants (g = 0.885). Dawes et al. (2006) examined walk time in 18 participants with mixed disorders (g = 0.419), while Oorschot et al. (2025) assessed walking endurance capacity distance among 76 participants receiving aerobic exercise plus coaching (g = 0.211). Additional trials encompassed Aslan et al. (2014) evaluating respiratory training against sham in 24 patients (g = 0.591), Jensen et al. (2024) testing resistance training in 32 myositis patients (g = 0.119), Jørgensen et al. (2018/2022) applying blood-flow-restricted training in 22 individuals with inclusion body myositis (g = 0.561), Muslihah et al. (2024) evaluating cycling in 22 myasthenia gravis patients (g = 1.200), Shrader et al. (2015) testing exercise in 50 participants with spinal and bulbar muscular atrophy (g = 0.123), and Wiesinger et al. (1998) assessing activities of daily living in 14 polymyositis or dermatomyositis patients (g = 0.744).

To synthesize these trials without dependency from multiple correlated outcomes within studies, the authors established a standardized outcome hierarchy. Precedence was assigned to walking endurance or exercise capacity, followed by task-based functional performance or mobility, and finally single functional or symptom measures. In addition to the primary one-effect-per-trial model, researchers fitted a supportive two-level random-effects model using restricted maximum likelihood estimation retaining all 21 valid effects nested within trials. Assuming independent sampling errors among within-trial effects, the supportive multilevel model yielded a consistent positive pooled estimate (g = 0.511, standard error = 0.129, z = 3.96, 95% confidence interval 0.258 to 0.764; p < 0.001). A three-level sensitivity meta-analysis incorporating random intercepts for both trial and effect nested within trial yielded an identical summary estimate, with trial-level variance estimated at tau-squared approximately 0.108 and effect-level variance approaching zero.

Exploratory subgroup analyses by disease category demonstrated no statistically significant treatment moderation across diagnostic classifications. The primary disease-category omnibus test yielded a non-significant result (p = 0.518), corroborated by the three-level omnibus model (p = 0.899). Subgroup effect estimates calculated using modified Knapp-Hartung inference displayed notable imprecision due to sparse study numbers. Muscular dystrophy, comprising four trials, yielded an estimated effect size of g = 0.70 (95% confidence interval −0.39 to 1.79); myositis, encompassing three trials, demonstrated g = 0.38 (95% confidence interval −0.68 to 1.44); and related neuromuscular conditions, containing five trials, produced g = 0.35 (95% confidence interval −0.09 to 0.80). Metabolic myopathy was represented by a single trial yielding g = 1.30 (95% confidence interval 0.27 to 2.33). The authors cautioned that these sparse subgroup estimates cannot establish clinical equivalence or confirm diagnosis-specific therapeutic efficacy.

Evaluations across functional outcome domains were restricted to descriptive summaries because several domains contained single trials. Walking endurance and exercise capacity encompassed seven trials with a summary effect of g = 0.36 (95% confidence interval 0.02 to 0.70). Cardiorespiratory fitness was evaluated across four trials (g = 0.44, 95% confidence interval −0.17 to 1.05), functional performance across three trials (g = 0.26, 95% confidence interval −0.63 to 1.14), functional mobility time across two trials (g = 0.05, 95% confidence interval −3.50 to 3.60), and muscle strength across two trials (g = 0.15, 95% confidence interval −2.95 to 3.24). Three domains each contained a single trial: symptom burden (g = 1.20), fatigue and quality of life (g = 1.48), and respiratory function (g = 0.59). In exploratory meta-regression examining planned active exercise volume across eight dose-ready trials, no linear dose-response association was detected (slope = 0.019 in Hedges’ g per 100 minutes per week, 95% confidence interval −1.699 to 1.736; p = 0.980). A supportive multilevel regression across 14 effects likewise revealed no linear association (slope = −0.145 per 100 minutes per week, 95% confidence interval −1.326 to 1.037; p = 0.810), and no trial exceeded 1,200 minutes per week.

Sensitivity analyses confirmed the stability of the positive overall effect while illustrating the sensitivity of effect magnitude to underlying data structures. In primary leave-one-trial-out analyses, iteratively removing each trial produced pooled estimates ranging from g = 0.406 to 0.621, with all 13 resulting confidence intervals remaining entirely above zero. Supportive multilevel leave-one-out estimates ranged from g = 0.361 to 0.564, consistently maintaining positive statistical significance. However, when synthesis was restricted to eight trials providing post-intervention endpoint data—excluding studies relying on change scores or adjusted models—the summary effect attenuated to g = 0.335 (95% confidence interval 0.007 to 0.663; p = 0.046). Evaluation of small-study effects through a contour-enhanced funnel plot and Egger’s linear regression test revealed an intercept of 1.691 (p = 0.238), indicating no statistically significant asymmetry. An exploratory trim-and-fill analysis converged without imputing missing studies, leaving the pooled estimate at g = 0.567. Nevertheless, the investigators noted that publication bias tests possess limited statistical power in small meta-analyses.

Methodological quality assessments conducted with the Cochrane Risk of Bias 2 (RoB 2) tool revealed widespread methodological vulnerabilities across the analyzed literature. Among 19 randomized trials with outcome data evaluated across the wider review, 13 were judged to raise some concerns and six were classified as carrying a high overall risk of bias, with none achieving a low risk of bias rating. Within the 13 trials contributing to the primary meta-analysis, three were rated at high risk of bias and ten raised some concerns. Specific assessments highlighted Ballaz et al. (2026), which raised some concerns due to absence of documented sequence generation, allocation concealment, assessor blinding, and prospective protocol registration, and Öztürk et al. (2026), which was judged at high risk of bias because unblinded participants and physiotherapists assessed a subjective symptom measure. Furthermore, a non-randomized matched comparison by Kilic et al. (2025) was excluded from quantitative synthesis due to unadjusted confounding inherent to its non-randomized design.

Under the GRADE framework, the overall certainty of evidence for functional outcomes was formally rated as low. Although the primary 95% confidence interval excluded no effect and its lower limit exceeded the conventional small standardized-effect benchmark of 0.20, the total analysis denominator of 403 participants fell well below the optimal information size benchmark of approximately 788 participants required to achieve 80% statistical power. Consequently, the investigators applied downgrades for serious risk of bias and serious imprecision, while treating statistical heterogeneity separately (I-squared = 44.8%; tau-squared = 0.117). The authors also noted that the review did not synthesize adverse events, creatine kinase elevations, disease progression parameters, or intervention adherence, precluding claims of universal exercise safety or community delivery efficacy. The findings support continued research into structured exercise for neuromuscular conditions while emphasizing that clinical rehabilitation must remain individualized and guided by disease-specific medical monitoring rather than generalized prescriptive thresholds.

Subject of Research: Meta-analytic evaluation of structured exercise and functional outcomes in neuromuscular diseases

Article Title: Structured exercise is associated with improved functional outcomes in myopathies and related neuromuscular diseases: a systematic review and exploratory dose-response meta-analysis

Article References: Chen, X., Lu, Q., Liu, D., & Chai, Y. (2026). Structured exercise is associated with improved functional outcomes in myopathies and related neuromuscular diseases: a systematic review and exploratory dose-response meta-analysis. Frontiers in Public Health, 14, Article 1997358. https://doi.org/10.3389/fpubh.2026.1997358

Image Credits: AI Generated

DOI: 10.3389/fpubh.2026.1997358

Keywords: structured exercise, myopathies, neuromuscular diseases, functional outcomes, systematic review, meta-analysis, Hedges' g, random-effects model, dose-response meta-regression, Knapp-Hartung inference, GRADE certainty, walking endurance, muscular dystrophy, inflammatory myopathies, myotonic dystrophy, physical rehabilitation, risk of bias, prediction interval

News Source: Ophelia Keating. (November 16, 2026). Meta-Analysis Links Structured Exercise to Functional Improvements in Neuromuscular Diseases. Scienmag.

Tags: dose-response meta-regressionFunctional outcomesGRADE certaintyHedges’ ginflammatory myopathiesKnapp-Hartung inferenceMeta-analysismuscular dystrophymyopathiesmyotonic dystrophyneuromuscular diseasesphysical rehabilitationprediction intervalrandom-effects modelrisk of biasstructured exercisesystematic reviewwalking endurance
Share12Tweet7Share2ShareShareShare1

Related Posts

Fusobacterium nucleatum Extracellular Vesicles Trigger Neuroinflammation and Anxiety-Like Behaviors via IL-1β

Fusobacterium nucleatum Extracellular Vesicles Trigger Neuroinflammation and Anxiety-Like Behaviors via IL-1β

November 17, 2026
Immune Cell Exhaustion May Drive Neurodegeneration in Alzheimer's and Parkinson's

Immune Cell Exhaustion May Drive Neurodegeneration in Alzheimer’s and Parkinson’s

November 17, 2026

Posterior Cruciate Ligament Continuously Lengthens Across Knee Flexion in Healthy Adults

November 17, 2026

3D-Printed Guide Template Associated With Improved Spinal Deformity Correction in Cohort

November 17, 2026

POPULAR NEWS

  • Review Highlights Multi-Level Factors Influencing Clinical AI Adoption by Healthcare Providers

    Review Highlights Multi-Level Factors Influencing Clinical AI Adoption by Healthcare Providers

    29 shares
    Share 12 Tweet 7
  • Gut Microbiota and Metabolites Influence Immunotherapy Response in Liver Cancer

    29 shares
    Share 12 Tweet 7
  • Nonlinear Sex-Specific Remodeling of the TCRβ Repertoire During Adult Aging

    29 shares
    Share 12 Tweet 7
  • Capped Nanovials Enable Extended Cell Growth and Screening in UCLA Study

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Fusobacterium nucleatum Extracellular Vesicles Trigger Neuroinflammation and Anxiety-Like Behaviors via IL-1β

Experiential Workshop Expands Mexican Students’ Understanding of Bat Diets and Ecological Roles

Immune Cell Exhaustion May Drive Neurodegeneration in Alzheimer’s and Parkinson’s

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.